Hims & Hers (HIMS) Director Manuel Anja Receives RSU Award

What Happened

• Manuel Anja, a director of Hims & Hers Health, Inc. (HIMS), received a grant of 8,223 Restricted Stock Units (RSUs) on 2026-08-12. The Form 4 reports the RSUs as a derivative acquisition at $0.00; RSUs are a contingent right to receive one share of Class A common stock per RSU upon vesting. No cash was paid and no shares were immediately issued or sold.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (timely filing).
• Grant: 8,223 RSUs; reported acquisition price: $0.00 (derivative award).
• Shares owned after transaction: not specified in the filing.
• Footnote: RSUs vest in full on the first company quarterly vesting date after the earlier of (x) the next annual stockholder meeting or (y) the first anniversary of the grant, subject to continuous service (see footnote F1).
• No 10b5-1 plan, tax-withholding sale, or immediate cashless exercise noted.

Context

• RSUs are compensation awards that convert to actual shares only upon vesting; they are not immediate open-market purchases or sales and do not necessarily signal buying or selling intent. This is a routine equity grant to an insider, reported as a derivative award rather than an immediate share transfer.